The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2009
Filed:
Feb. 09, 2005
Louise Edwards, Mississauga, CA;
Methvin Isaac, Mississauga, CA;
Martin Johansson, Södertälje, SE;
Annika Kers, Södertälje, SE;
Johan Malmberg, Södertälje, SE;
Donald Mcleod, Salt Lake City, UT (US);
Alexander Mindis, Södertälje, SE;
Karin Staaf, Södertälje, SE;
Abdelmalik Slassi, Mississauga, CA;
Tomislav Stefanac, Mississauga, CA;
Thomas Stormann, Salt Lake City, UT (US);
David Wensbo, Södertälje, SE;
Tau Xin, Mississauga, CA;
Jalaj Arora, Mississauga, CA;
Louise Edwards, Mississauga, CA;
Methvin Isaac, Mississauga, CA;
Martin Johansson, Södertälje, SE;
Annika Kers, Södertälje, SE;
Johan Malmberg, Södertälje, SE;
Donald McLeod, Salt Lake City, UT (US);
Alexander Mindis, Södertälje, SE;
Karin Staaf, Södertälje, SE;
Abdelmalik Slassi, Mississauga, CA;
Tomislav Stefanac, Mississauga, CA;
Thomas Stormann, Salt Lake City, UT (US);
David Wensbo, Södertälje, SE;
Tau Xin, Mississauga, CA;
Jalaj Arora, Mississauga, CA;
AstraZeneca AB, Sodertalje, SE;
Abstract
The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.